Search This Blog

Tuesday, August 6, 2019

Sage Therapeutics EPS beats by $0.10, beats on revenue

Sage Therapeutics (NASDAQ:SAGE): Q2 GAAP EPS of -$3.28 beats by $0.10.
Revenue of $0.87M (-99.0% Y/Y) beats by $0.6M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)